Main Article Content
Covid-19, pollution, smoking, inflammation
Coronavirus disease (COVID-19) is an infectious disease caused by the newly discovered coronavirus, Sars-Cov-2. This infection can cause mild to very severe respiratory and systemic illness mainly related with a cytokine storm. The epidemiology of COVID-19 is under continuous evolution, and studies are ongoing aiming at identifying the possible factors facilitating the diffusion of this infection.
It is documented that air pollution and smoking are a leading cause of human morbidity and mortality globally, and can increase the risk of many diseases, including respiratory diseases. Overall, a linear relationship between exposure to atmospheric pollutants and diffusion of the Sars-Cov2 virus seems to exist. However, this correlation, cannot be regarded as a cause-effect relationship. The available data show that air pollution is responsible for inflammation and hyper-activation of innate immunity that are associated with the worst outcomes of covid-19 but do not allow to conclude that atmospheric particulate is responsible for increased contagion. As to smoking, nicotine activation of nicotinic receptors leads to enhanced protease activation, apoptosis and inflammatory signaling through the same pathways (Renin-angiotensin system (RAS) and angiotensin-converting enzyme 2 (ACE2)) used by the virus increasing the inflammatory/destructive action of the virus itself.
The increase in non-communicable diseases and of chronic inflammatory diseases is in line with environmental pollution, related climate changes, and with an augmented susceptibility to infectious diseases with increased contagiousness and morbidity. Restrictive measures to limit environmental pollution are needed worldwide as this represents a threat for human health.
2. Sun, P, Lu, X, Xu, C, Sun, W, Pan, B. Understanding of COVID‐19 based on current evidence. J Med Virol. 2020; 92: 548– 551.
3. U.S. EPA. Air Quality Criteria For Ozone And Related Photochemical Oxidants (Final Report, 2006). U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-05/004aF-cF, 2006.
4. Cao C, Jiang W, Wang B, et al. Inhalable microorganisms in Beijing's PM2.5 and PM10 pollutants during a severe smog event. Environ Sci Technol. 2014;48(3):1499‐1507.
5. Despres VR, Huffman J, Burrows S, Hoose C, Safatov A, Buryak Gert al. Primary biological aerosol particles in the atmosphere: a review, Tellus B: Chemical and Physical Meteorology, 2012; 64, 15598. doi: 10.3402/tellusb.v64i0.15598
6. Hochscheid R, Schuchmann U, Kotte E, Kranz S, Heinrichs S, Müller B.NO2-induced acute and chronic lung injury cause imbalance of glutathione metabolism in type II pneumocytes. Med Sci Monit. 2005 Aug;11(8):BR273-9.
7. Jaspers I, Ciencewicki JM, Zhang W, Brighton LE, Carson JL, Beck MA et al. Diesel exhaust enhances influenza virus infections in respiratory epithelial cells. Toxicol Sci. 2005;85(2):990‐1002.
8. Hiraiwa K, van Eeden SF. Contribution of lung macrophages to the inflammatory responses induced by exposure to air pollutants. Mediators Inflamm. 2013;2013:619523. doi: 10.1155/2013/619523
9. Rylance J, Fullerton DG, Scriven J, Aljurayyan AN, Mzinza D, Barrett S et al. Household air pollution causes dose-dependent inflammation and altered phagocytosis in human macrophages. Am J Respir Cell Mol Biol. 2015 May;52(5):584-93.
10. Silveyra P, Floros J. Air pollution and epigenetics: effects on SP-A and innate host defence in the lung. Swiss Med Wkly. 2012 May 2;142:w13579. doi: 10.4414/smw.2012.13579.
11. Ciencewicki J, Jaspers I. Air Pollution and Respiratory Viral Infection, Inhal Toxicol. 2007 Nov; 19(14): 1135–1146.
12. Jaakkola J.K, Paunio M., Vutanen M., and Heinonen P. Low-Level Air Pollution and Upper Respiratory Infections in Children. Am. J. Public Health,1991. 81:1060–1063.
13. Ye Q, Fu JF, Mao JH, Shang SQ. Haze is a risk factor contributing to the rapid spread of respiratory syncytial virus in children. Environ Sci Pollut Res Int. 2016;23(20):20178-20185.
14. Horne B, Joy EA, Hofmann MG, Gesteland P, Cannon JB, Lefler JS et al. Short-Term Elevation of Fine Particulate Matter Air Pollution and Acute Lower Respiratory Infection. Am J Respir Crit Care Med. 2018 Sep 15;198(6):759-766.
15. Peng L, Zhao X, Tao Y, Mi S, Huang J, Zhang Q. The effects of air pollution and meteorological factors on measles cases in Lanzhou, China. Environ Sci Pollut Res Int. 2020 Apr;27(12):13524-13533.
16. Cui Y, Zhang ZF, Froines J, Zhao J, Wang H, Yu SZ, Detels R. Air pollution and case fatality of SARS in the People's Republic of China: an ecologic study. Environ Health. 2003 Nov 20;2(1):15. doi: 10.1186/1476-069X-2-15.
17. Kan HD, Chen BH, Fu CW, Yu SZ, Mu LN. Relationship between ambient air pollution and daily mortality of SARS in Beijing. Biomed Environ Sci. 2005 Feb;18(1):1-4.
18. Setti L, Passarini F, de Gennaro G, Di Gilio A, Palmisani J, Buono P, et al. Evaluation of the potential relationship between Particulate Matter (PM) pollution and COVID-19 infection spread in Italy. SIMA Position Pap. 2020. Available from: http://www.simaonlus.it/?page_id=694
19. Conticini E, Frediani B, Caro D. Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy? Environmental Pollution, 2020; 114465 doi: 10.1016/j.envpol.2020.114465.
20. World's Air Pollution: Real-time Air Quality Index. Map available at: https://waqi.info/it/
21. Yang J, Chen Y, Yu Z, Ding H, Ma Z. The influence of PM(2.5) on lung injury and cytokines in mice. Exp Ther Med. 2019 Oct;18(4):2503-2511.
22. Pope CA 3rd, Bhatnagar A, McCracken JP, Abplanalp W, Conklin DJ, O'Toole T. Exposure to Fine Particulate Air Pollution Is Associated With Endothelial Injury and Systemic Inflammation. Circ Res. 2016 Nov 11;119(11):1204-1214.
23. Tsai DH, Riediker M, Berchet A, Paccaud F, Waeber G, Vollenweider P, Bochud M. Effects of short- and long-term exposures to particulate matter on inflammatory marker levels in the general population. Environ Sci Pollut Res Int. 2019 Jul;26(19):19697-19704.
24. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi:10.1016/j.tmaid.2020.101623.
25. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):e38. doi:10.1056/NEJMc2007575.
26. Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C et al. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol. 2020 Jan 29;10:1607. doi:10.3389/fphys.2019.01607.
27. Galcheva SV, Iotova VM, Yotov YT, Bernasconi S, Street ME. Circulating proinflammatory peptides related to abdominal adiposity and cardiometabolic risk factors in healthy prepubertal children. Eur J Endocrinol. 2011 Apr;164(4):553-8.
28. Sattar N, McInnes IB, McMurray JJV. Obesity a risk factor for severe COVID-19 Infection: multiple potential mechanisms. Circulation 2020 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.047659.
29. Zheng KI, Gao F, Wang XB, Sun QF, Pan KH, Wang TY et al. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism. 2020 Apr 19;108:154244. doi: 10.1016/j.metabol.2020.154244.
30. Cao Y, Chen M, Dong D, Xie S, Liu M. Environmental pollutants damage airway epithelial cell cilia: Implications for the prevention of obstructive lung diseases. Thorac Cancer. 2020 Mar;11(3):505-510.
31. Aisiku IP, Yamal JM, Doshi P, Benoit JS, Gopinath S, Goodman JC, et al. Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury. Crit Care. 2016 doi: 10.1186/s13054-016-1470-7
32. Gouda MM, Shaikh SB, Bhandary YP. Inflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome. Lung. 2018 Oct;196(5):609-616.
33. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M,et al. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 2004 Jun 1;109(21):2655-71.
34. Di Q, Wang Y, Zanobetti A, Wang Y, Koutrakis P, Choirat C, et al. Air Pollution and Mortality in the Medicare Population. N Engl J Med. 2017 Jun 29;376(26):2513-2522.
35. Puett RC, Hart JE, Yanosky JD, Paciorek C, Schwartz J, Suh H et al. Chronic fine and coarse particulate exposure, mortality, and coronary heart disease in the Nurses' Health Study. Environ Health Perspect. 2009 Nov;117(11):1697-701.
36. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA. 2006;295(10):1127–34.
37. Wellenius G, Burger MR, Coull BA, Schwartz J, Suh HH, Koutrakis P, et al. Ambient air pollution and the risk of acute ischemic stroke. Arch Intern Med. 2012 Feb 13;172(3):229-34.
38. Di Q, Dai L, Wang Y, Zanobetti A, Choirat C, Schwartz JD et al.Association of Short-term Exposure to Air Pollution With Mortality in Older Adults. JAMA. 2017 Dec 26;318(24):2446-2456.
39. Wu X, Nethery RC, Sabath BM, Braun D, Dominici F. Exposure to air pollution and COVID-19 mortality in the United States. MedRxiv. 2020 doi: 10.1101/2020.04.05.20054502
40. Shin S, Bai L, Oiamo TH, Burnett RT, Weichenthal S, Jerrett M et al.Association Between Road Traffic Noise and Incidence of Diabetes Mellitus and Hypertension in Toronto, Canada: A Population-Based Cohort Study. J Am Heart Assoc. 2020 Mar 17;9(6):e013021. doi:10.1161/JAHA.119.013021.
41. Gan WQ, Davies HW, Koehoorn M, Brauer M. Association of long-term exposure to community noise and traffic-related air pollution with coronary heart disease mortality. Am J Epidemiol. 2012 May 1;175(9):898-906.
42. Mann JK, Tager IB, Lurmann F, Segal M, Quesenberry CP, Lugg MM, et al. Air pollution and hospital admissions for ischemic heart disease in persons with congestive heart failure or arrhythmia.Environ. Health Perspect.2002 110, 1247–1252.
43. Abbey DE, Colome SD, Mills PK, Burchette R, Beeson WL, Tian Y. Chronic disease associated with long-term concentrations of nitrogen dioxide. J Expo Anal Environ Epidemiol. 1993 Apr-Jun;3(2):181-202.
44. Avol EL, Gauderman WJ, Tan SM, London SJ, Peters JM. Respiratory effects of relocating to areas of differing air pollution levels. Am J Respir Crit Care Med. 2001 Dec 1;164(11):2067-72.
45. Bowatte G, Erbas B, Lodge CJ, Knibbs LD, Gurrin LC, Marks GB, et al. Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age. Eur Respir J. 2017 Oct 26;50(4), 1602357. doi: 10.1183/13993003.02357-2016.
46. Ogen Y. Assessing nitrogen dioxide (NO(2)) levels as a contributing factor to coronavirus (COVID-19) fatality. Sci Total Environ. 2020 Apr 11;726:138605. doi: 10.1016/j.scitotenv.2020.138605.
47. Changeux JP. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat Rev Neurosci. 2010 Jun;11(6):389-401.
48. Freitas K, Ghosh S, Ivy Carroll F, Lichtman AH, Imad Damaj M. Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models. Neuropharmacology. 2013 Feb;65:156-64.
49. Nordman JC, Muldoon P, Clark S, Damaj MI, Kabbani N. The α4 nicotinic receptor promotes CD4+ T-cell proliferation and a helper T-cell immune response. Mol Pharmacol. 2014 Jan;85(1):50-61
50. Olds JL, Kabban N. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? The Febs Journal, 2020 Mar. doi: 10.1111/febs.15303
51. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.
52. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637.
53. Marshall RP. The pulmonary renin-angiotensin system. Curr Pharm Des. 2003;9(9):715-22.
54. Hung YH, Hsieh WY, Hsieh JS, Liu FC, Tsai CH, Lu LC et al. Alternative Roles of STAT3 and MAPK Signaling Pathways in the MMPs Activation and Progression of Lung Injury Induced by Cigarette Smoke Exposure in ACE2 Knockout Mice. Int J Biol Sci. 2016 Feb 12;12(4):454-65.
55. Parajuli N, Ramprasath T, Patel VB, Wang W, Putko B, Mori J et al. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases. Can J Physiol Pharmacol. 2014 Jul;92(7):558-65.
56. Lee YB, Nagai A, Kim SU. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res. 2002 Jul 1;69(1):94-103.
57. Dagenais NJ, Jamali F. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions. Pharmacotherapy. 2005 Sep;25(9):1213-29.
58. Patel VB, Basu R, Oudit GY. ACE2/Ang 1-7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity. Adipocyte. 2016 Jan 6;5(3):306-11.
59. Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. 2020 doi: 10.1101/2020.02.05.20020107
60. Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tobacco Induced Diseases. 2020;18(March):20. doi:10.18332/tid/119324.
61. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720